Nath Bio-Genes (India) Limited Cash Flow Conversion Efficiency

Latest as of September 2025: -0.160x

Nath Bio-Genes (India) Limited cash flow conversion efficiency. Based on the latest financial reports, Nath Bio-Genes (India) Limited (NATHBIOGEN) has a cash flow conversion efficiency ratio of -0.160x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.09 Billion ≈ $-11.75 Million USD) by net assets (Rs6.80 Billion ≈ $73.52 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Nath Bio-Genes (India) Limited (2013–2026)

Cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2026. This chart illustrates how Nath Bio-Genes (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nath Bio-Genes (India) Limited stock quote for real-time trading data and today's change.

Nath Bio-Genes (India) Limited Cash Flow Conversion Ratio Explained

Nath Bio-Genes (India) Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Nath Bio-Genes (India) Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nath Bio-Genes (India) Limited ranked by their cash flow conversion efficiency. Also see how much is Nath Bio-Genes (India) Limited worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Sunstone Metals Ltd AU:STM	-0.010x
Valor Energy Inc. NASDAQ:VAI	0.025x
Pioneer Power Solutions Inc. NASDAQ:PPSI	-0.033x
SAF Tehnika A/S F:VTZ	0.104x
Biocartis Group NV BR:BCART	0.542x
Groupe Canal Plus LSE:CAN	0.047x
Sierra Nevada Gold Inc AU:SNX	-0.044x
Nova EYE Medical Ltd AU:EYE	-0.059x

Annual Cash Flow Conversion Efficiency for Nath Bio-Genes (India) Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Nath Bio-Genes (India) Limited from 2013 to 2026. Review NATHBIOGEN FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2026-03-31	Rs6.80 Billion ≈ $73.59 Million	Rs-220.35 Million ≈ $-2.38 Million	-0.032x	-218.69%
2025-03-31	Rs6.44 Billion ≈ $69.69 Million	Rs175.81 Million ≈ $1.90 Million	0.027x	-72.93%
2024-03-31	Rs6.10 Billion ≈ $65.96 Million	Rs614.80 Million ≈ $6.65 Million	0.101x	+50.59%
2023-03-31	Rs5.73 Billion ≈ $61.99 Million	Rs383.67 Million ≈ $4.15 Million	0.067x	+112.82%
2022-03-31	Rs5.42 Billion ≈ $58.61 Million	Rs170.46 Million ≈ $1.84 Million	0.031x	+1633.30%
2021-03-31	Rs6.13 Billion ≈ $66.32 Million	Rs11.13 Million ≈ $120.35K	0.002x	-89.32%
2020-03-31	Rs5.58 Billion ≈ $60.30 Million	Rs94.74 Million ≈ $1.02 Million	0.017x	+139.22%
2019-03-31	Rs5.08 Billion ≈ $54.89 Million	Rs-219.89 Million ≈ $-2.38 Million	-0.043x	+56.74%
2018-03-31	Rs4.69 Billion ≈ $50.75 Million	Rs-469.84 Million ≈ $-5.08 Million	-0.100x	-512.04%
2017-03-31	Rs1.38 Billion ≈ $14.88 Million	Rs33.43 Million ≈ $361.58K	0.024x	+120.81%
2016-03-31	Rs1.21 Billion ≈ $13.12 Million	Rs-141.68 Million ≈ $-1.53 Million	-0.117x	-285.23%
2015-03-31	Rs1.07 Billion ≈ $11.59 Million	Rs67.55 Million ≈ $730.58K	0.063x	-65.69%
2014-03-31	Rs817.78 Million ≈ $8.84 Million	Rs150.28 Million ≈ $1.63 Million	0.184x	-25.68%
2013-03-31	Rs574.74 Million ≈ $6.22 Million	Rs142.11 Million ≈ $1.54 Million	0.247x	--

About Nath Bio-Genes (India) Limited

NSE:NATHBIOGEN India Agricultural Inputs

Market Cap

$27.27 Million

Rs2.52 Billion INR

Market Cap Rank

#23908 Global

#1313 in India

Share Price

Rs132.67

Change (1 day)

+0.60%

52-Week Range

Rs129.02 - Rs196.01

All Time High

Rs537.81